CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-08 | Gallagher Carol Giltner Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,500 | 21,500 | ||
| 2017-06-08 | MARCUS JOEL S Director | Grant or award | +5,000 | 7,000 | ||
| 2017-06-08 | MARCUS JOEL S Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,500 | 21,500 | ||
| 2017-06-08 | HEIDEN WILLIAM K Director | Grant or award | +5,000 | 7,000 | ||
| 2017-06-08 | HEIDEN WILLIAM K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,500 | 21,500 | ||
| 2017-06-08 | Fust Matthew K Director | Grant or award | +5,000 | 27,298 | ||
| 2017-06-08 | Fust Matthew K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,500 | 21,500 | ||
| 2017-06-08 | DOBMEIER ERIC Director | Grant or award | +5,000 | 12,500 | ||
| 2017-06-08 | DOBMEIER ERIC Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,500 | 21,500 | ||
| 2017-05-31 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,450 | $13.26 | $46K | 456,078 |
| 2017-05-30 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,450 | $13.44 | $46K | 459,528 |
| 2017-05-18 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $14.94 | $36K | 462,978 |
| 2017-05-17 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $14.88 | $36K | 465,378 |
| 2017-05-16 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −2,000 | $15.27 | $31K | 117,460 |
| 2017-05-16 | Gallagher Carol Giltner Director | Sale | −1,184 | $15.25 | $18K | 103,374 |
| 2017-05-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +935 | 113,762 | ||
| 2017-05-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +7,698 | 121,460 | ||
| 2017-05-15 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −2,000 | $14.95 | $30K | 119,460 |
| 2017-05-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −935 | 0 | ||
| 2017-05-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −7,698 | 20,526 |
Page 43 of 44 · 867 trades